Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry denotes a pseudogene corresponding to the beta-1,3-galactosyltransferase 3 gene family, which codes for non-functional genomic DNA sequences similar in structure to active galactosyltransferase genes. Unlike its functional paralogs, it does not encode a protein product, is not implicated in catalytic activity, and does not function as a druggable target. Key distinctions: - The functional family members (e.g., B3GALT1, B3GALT2) synthesize glycan chains in glycoproteins and glycolipids, playing roles in cell–cell recognition and possibly in disease[1][2]. - Pseudogenes like the one described here are productless remnants of gene duplication or retrotransposition events and do not participate in these processes. Summary: This target is a non-functional, non-coding pseudogene and is not a receptor, enzyme, or other druggable protein. No aliases, functions, disease roles, or drug interactions applicable. Any attempt to use this as a therapeutic target or experimental receptor would be incorrect based on current genomic annotation. If you were instead seeking information about a functional beta-1,3-galactosyltransferase, such as B3GALT1 or B3GALT2, those are enzymes involved in glycan biosynthesis and may have biological and disease significance[1][2][4]. This is NOT the case for ENSG00000225711.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UDP-Gal:betaGlcNAc beta-1,3-galactosyltransferase, polypeptide 3 pseudogene.